Navigation Links
New Jersey Health Foundation Awards $50,000 Grant For Research to Facilitate Stem Cell Growth
Date:10/21/2013

NEW BRUNSWICK, N.J., Oct. 21, 2013 /PRNewswire-USNewswire/ -- Dr. Steven Levison has received a $50,000 Innovation Stage Funding Grant from New Jersey Health Foundation to advance research that could make stem cell growth easier and less expensive for researchers, scientists and others interested in using stem cells to advance medical studies.

Dr. Levison, a professor in the Department of Neurology and Neurosciences at Rutgers New Jersey Medical School (NJMS), has worked collaboratively with colleagues at NJMS and at the New Jersey Institute of Technology to develop a multifunctional matrix that allows neural stem cells to be propagated as undifferentiated cells without daily feeding.

"Our cell culture matrices and supplements can be used in regenerative medicine, biotechnology and life science research," explained Dr. Levison. "We can manufacture products that don't contain animal components so that they are suitable for clinical applications."

Dr. Levison explained that he and his research team have formulated and rigorously tested a novel growth matrix that promotes the proliferation and multipotency of neural stem cells. Commercially available matrices today, he said, do not incorporate defined growth factors.  While some matrices do contain growth factors, they are not defined or suitable for therapeutic use.

"We are very interested in helping Dr. Levison advance his research because we believe this product could be commercialized successfully to be of tremendous benefit to the research community," explained Dr. George F. Heinrich, vice chair and CEO of New Jersey Health Foundation.  "His unique product reduces the time-consuming and tedious task of feeding stem cells on a daily basis, which will save researchers time and money."

Dr. Levison and his research team are presently modifying the scaffold to incorporate a variety of growth factors known to be beneficial for propagating other types of stem cells and progenitors. 

Through the Innovation Stage Funding program, New Jersey health Foundation (www.njhf.org) has allocated $500,000 to provide grants from $10,000 to $50,000 each to researchers at the Rutgers School of Biomedical and Health Sciences who have promising ideas to advance an intellectual property toward commercialization through a start-up. 

About New Jersey Health Foundation
New Jersey Health Foundation (www.njhf.org) is a not-for-profit corporation that supports biomedical research and health-related education programs in New Jersey through its matching program, its Grants Program and its affiliate, Foundation Venture Capital Group (www.foundationventure.com) which makes private equity investments in life science start- up companies in New Jersey headed toward commercialization.


'/>"/>
SOURCE New Jersey Health Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunrise Pharmaceutical, Inc. Sued for Violation of New Jersey Consumer Fraud Act
2. Cardiac Science signs contract to provide Powerheart AEDs to the state of New Jersey
3. Big Pharma to Come Together at ChemOutsourcing 2013 in Long Branch, New Jersey, Sept 16-19
4. ChemOutsourcing Announces 100 CMO and CRO Exhibitors for September 2013 Show in Long Branch, New Jersey
5. ChemOutsourcing Announces 30 Pharma Company Presenters for September 2013 Outsourcing Show in New Jersey
6. NJBIZ Honors New Jerseys General Counsels
7. Growth Fuels Expansion As PendoTECH Relocates New Jersey Headquarters
8. South Jersey Healthcare Selects Perioperative Management By Surgical Information Systems
9. New Jersey Health Foundation Awards First Two Innovation Stage Funding Grants
10. Ferring Pharmaceuticals Inc. Named 10th Fastest Growing New Jersey Company
11. Eisai USA Foundation to Donate $100,000 to the Hurricane Sandy New Jersey Relief Fund, $50,000 to the American Red Cross
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):